APOE and obesity due to melanocortin 4 receptor deficiency: These findings identify an important gene-environment interaction that may have significant impact for understanding Alzheimer’s risk and etiology and promoting development of targeted therapeutic approaches that incorporate both obesity and APOE genotype.